We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.01B
AUM Growth
+$275M
Cap. Flow
+$223M
Cap. Flow %
22.14%
Top 10 Hldgs %
24.16%
Holding
3,706
New
246
Increased
2,543
Reduced
445
Closed
132

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$11.6M
2
NVDA icon
NVIDIA
NVDA
+$8.23M
3
MSFT icon
Microsoft
MSFT
+$7.53M
4
AMZN icon
Amazon
AMZN
+$3.51M
5
META icon
Meta Platforms (Facebook)
META
+$3.34M

Sector Composition

Rank Sector Weight
1 Technology 24.3%
2 Financials 11.78%
3 Healthcare 9.71%
4 Industrials 7.92%
5 Consumer Discretionary 7.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VERV
2176
DELISTED
Verve Therapeutics
VERV
$10.1K ﹤0.01%
2,090
-15,033
-88% -$87.3K
UVE icon
2177
Universal Insurance Holdings
UVE
$1.21B
$10.1K ﹤0.01%
456
+196
+75% +$3.96K
AVUV icon
2178
Avantis US Small Cap Value ETF
AVUV
$30.8B
$10.1K ﹤0.01%
105
PSTL
2179
Postal Realty Trust
PSTL
$680M
$10.1K ﹤0.01%
687
+429
+166% +$6.16K
PSN icon
2180
Parsons
PSN
$4.93B
$10.1K ﹤0.01%
+97
New +$8.7K
PRLB icon
2181
Protolabs
PRLB
$2.14B
$10K ﹤0.01%
342
+163
+91% +$4.97K
FOLD
2182
DELISTED
Amicus Therapeutics
FOLD
$10K ﹤0.01%
938
+326
+53% +$3.55K
HAFC icon
2183
Hanmi Financial
HAFC
$939M
$10K ﹤0.01%
538
+54
+11% +$1.01K
SASR
2184
DELISTED
Sandy Spring Bancorp Inc
SASR
$10K ﹤0.01%
319
+215
+207% +$6.35K
BRKL
2185
DELISTED
Brookline Bancorp
BRKL
$10K ﹤0.01%
991
+434
+78% +$4.26K
ARQT icon
2186
Arcutis Biotherapeutics
ARQT
$3.26B
$9.83K ﹤0.01%
1,057
+5
+0.5% +$49
IEI icon
2187
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
$9.81K ﹤0.01%
82
AOSL icon
2188
Alpha and Omega Semiconductor
AOSL
$1.03B
$9.76K ﹤0.01%
263
+68
+35% +$2.58K
IXC icon
2189
iShares Global Energy ETF
IXC
$2.72B
$9.76K ﹤0.01%
241
CGEM icon
2190
Cullinan Oncology
CGEM
$1.18B
$9.74K ﹤0.01%
582
+78
+15% +$1.38K
USPH icon
2191
US Physical Therapy
USPH
$1.22B
$9.73K ﹤0.01%
115
+11
+11% +$976
LLYVK icon
2192
Liberty Live Group Series C
LLYVK
$9.61B
$9.7K ﹤0.01%
189
-38
-17% -$1.52K
TRVG
2193
trivago
TRVG
$376M
$9.64K ﹤0.01%
5,573
+2,347
+73% +$4.68K
RGNX icon
2194
Regenxbio
RGNX
$688M
$9.64K ﹤0.01%
919
+704
+327% +$8.58K
UEC icon
2195
Uranium Energy
UEC
$5.63B
$9.62K ﹤0.01%
1,549
+1,029
+198% +$5.58K
EMBC icon
2196
Embecta
EMBC
$283M
$9.6K ﹤0.01%
681
+422
+163% +$6.14K
XIFR
2197
XPLR Infrastructure LP
XIFR
$1.07B
$9.58K ﹤0.01%
+347
New +$9K
CCC
2198
CCC Intelligent Solutions
CCC
$4.11B
$9.55K ﹤0.01%
864
-858
-50% -$9.26K
TRS icon
2199
TriMas Corp
TRS
$1.43B
$9.52K ﹤0.01%
373
+279
+297% +$7K
IMMR icon
2200
Immersion
IMMR
$257M
$9.52K ﹤0.01%
1,067
+204
+24% +$2.08K

Similar funds

GAMMA Investing's Q3 2024 Portfolio in Review

As of Q3 2024, GAMMA Investing held 3,706 positions worth $1.01B, up 37% from $734M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

GAMMA Investing deployed $223M of net new capital in Q3 2024, opening 246 new positions and adding to 2,543 existing holdings. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 28,428 shares worth $2.61M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Chevron, an estimated $216K trimmed.

  • GAMMA Investing's largest Q3 2024 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 28,428 shares worth $2.61M.
  • GAMMA Investing added most to Apple in Q3 2024, an estimated $11.6M increase.
  • GAMMA Investing's biggest Q3 2024 reduction was Chevron, cutting an estimated $216K.
  • GAMMA Investing fully exited iShares iBonds 2025 Term High Yield and Income ETF in Q3 2024, selling an estimated $1.21M.
  • GAMMA Investing's ten largest holdings make up 24% of its $1.01B portfolio in Q3 2024.
  • GAMMA Investing opened 246 new positions and closed 132 in Q3 2024.
  • GAMMA Investing's portfolio value rose 37% quarter-over-quarter to $1.01B.

Based on GAMMA Investing's 13F filing for Q3 2024, filed 7 Oct 2024.